Good, Bad and Ugly — LABS, CRON, OGI Report. CBD & Vape Update [Cannabis StockCast #33]

The cannabis industry is in a slump — shares are down, even with companies growing revenue. Cronos, Medipharm Labs and Organigram all announced quarterly earnings. I breakdown how each company fared. I also discuss the vaping crisis and its development in the U.S., and recent news that may limit the use of CBD in medicine. Pot stocks have already entered the "acceleration phase" - learn everything you need to know to invest at the Marijuana Investment Symposium: https://pro.banyanhill.com/m/1406088 About Me: I joined Banyan Hill in 2017 as a research analyst. A market “outsider,” I use my science background to create an objective view of investments. This approach allows me to overcome the emotional biases that plague the average investor. My background in biogeography taught me to analyze giant data sets for specific patterns. That translates perfectly to financial research, and I now apply those tools to find opportunities to profit in natural resources. Follow me on Social Media! Twitter: https://twitter.com/ThePotStockGuru Facebook: https://www.facebook.com/ThePotStockGuru/ Instagram: https://www.instagram.com/thepotstockguru/ Like the info in this video? Comment below and let me know! I’d love to receive suggestions for new video topics, so feel free to share what you’d like to hear in future videos!